EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, InfuSystems Holdings's enterprise value is $207.3 Mil.
InfuSystems Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $125.8 Mil. Therefore, InfuSystems Holdings's EV-to-Revenue for today is 1.65.
The historical rank and industry rank for InfuSystems Holdings's EV-to-Revenue or its related term are showing as below:
INFU'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.92 Med: 1.57 Max: 5.3
Current: 1.65
During the past 13 years, the highest EV-to-Revenue of InfuSystems Holdings was 5.30. The lowest was 0.92. And the median was 1.57.
INFU's EV-to-Revenue is ranked better than 71.45% of 823
companies
in the Medical Devices & Instruments industry
Industry Median: 3.02
vs INFU: 1.65
InfuSystems Holdings EV-to-Revenue Historical Data
The historical data trend for InfuSystems Holdings's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of InfuSystems Holdings's EV-to-Revenue
For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's EV-to-Revenue falls into.
InfuSystems Holdings's current Enterprise Value is $207.3 Mil.
InfuSystems Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $125.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InfuSystems Holdings's share price for today is $8.12.
InfuSystems Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InfuSystems Holdings EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of InfuSystems Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
InfuSystems Holdings (InfuSystems Holdings) Business Description
InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INFU has been successfully added to your 